Abstract：Objective: To investigate the effect of oxymatrine on intestinal mucosal barrier damage and HMGB1 level in patients with severe pancreatitis.Method: A total of 120 patients with severe pancreatitis were selected as the research object,and were randomly vided into observation group and control group.The control group was given basic treatment,while the observation group was treated with Oxymatrine on the basis of the control group.The white blood cell recovery time,inflammatory factor level and intestinal mucosal barrier damage index level were observed.Results: The total effective rate of observation group was 93.33%,which was significantly higher than that of control group,P＜0.05;The abdominal pain relief time (3.58±1.02) d,first defecation time (3.09±0.68) d,blood amylase recovery time (4.58±1.45) d and white blood cell recovery time (5.05±1.33) d in the observation group were significantly lower,P＜0.05;After treatment,the levels of TNF-α(887.65±133.24)ng/L,IL-6(64.75±22.31)ng/L,IL-1(388.65±83.06)ng/L and HMGB1(32.43±23.67)μg/mL in the observation group were significantly lower,P＜0.05;After treatment,the levels of serum DAO (8.16±2.04) U/L,serum D-lactic acid (6.51±0.53) mg/L and botulinum toxin (16.42±6.87) EU/L in the observation group were significantly lower,P＜0.05.Conclusion: Oxymatrine combined with basic treatment for severe pancreatitis has significant clinical effect,can significantly reduce the level of inflammatory factors,improve the intestinal mucosal barrier function of patients,and is worthy of clinical application.
马德渊, 李山林, 李艳秋. 生长抑素乌司他汀联合氧化苦参碱对重症胰腺炎肠粘膜屏障损伤的改善及HMGB1水平的影响[J]. 河北医学, 2020, 26(11): 1877-1881.
Ma Deyuan, et al. Effect of Somatostatin, Ulinastatin Combined with Oxymatrine on Intestinal Mucosal Barrier Damage in Severe Pancreatitis and HMGB1 Level. HeBei Med, 2020, 26(11): 1877-1881.
2020, Vol. 26 
冀公网安备13080202000677号